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Maintenance of genome stability is a crucial cellular function for normal mammalian 
development and physiology. However, despite its general relevance, genome stability 
alteration due to genetic or non-genetic conditions has a particularly profound impact on 
the developing cerebral cortex. In this review we will analyse the principal pathways 
involved in maintenance of genome stability, the consequences of their alterations with 
regard to central nervous system development, as well as the possible molecular and 




Maintenance of genome stability is a complex cellular problem, handled by several 
interrelated mechanisms that ensure faithful duplication and segregation of genetic 
material during cell cycle, as well as its repair in proliferating or post-mitotic cells. 
Alterations of these mechanisms, due to genetic or non-genetic conditions, have severe 
consequences, such as cancerous transformation or altered embryonic development. 
Among the different tissues, developing human neocortex appears to be particularly 
vulnerable to alterations of genome stability, as the most common clinical manifestations 
of these disorders is microcephaly, which is the result of brain volume reduction. 
Microcephaly is a common clinical condition that may be evident at birth (primary or 
congenital microcephaly) or post-natally (secondary or progressive microcephaly). In the 
hereditary forms, microcephaly may be the only defect observed (non-syndromic 
microcephaly or MCPH) or be associated with other malformations (syndromic 
microcephaly) [1]. Dissecting the molecular and cellular mechanisms implicated in genetic 
primary microcephaly could also be critical to better understand non-genetic forms, such 
as intrauterine insults, viral infections [2] [3] or alcohol/drug abuse during pregnancy [4]. In 
theory, any condition that alters neural progenitor expansion or their survival may induce 
microcephaly. However, despite the more or less specific alteration of brain development 
that characterize microcephaly syndromes, the identification of causal mutations has 
revealed that they mostly occur in ubiquitously expressed genes, whose products are 
tightly involved in cell proliferation and maintenance of genomic stability. Understanding 
the reasons of this specificity is in most cases an open issue. In this review, we will 
summarize the main cellular events in the development of the cerebral cortex, with 
particular emphasis on those that may distinguish cortical progenitors from other 
developing cell types. We will also underscore the evidence of specific sensitivity of neural 
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progenitors to genome integrity. Then, we will analyze the genetic causes of microcephaly, 
grouping the different syndromes on the basis of the main molecular process involved. 
Finally, we will try to highlight how the interaction between different mechanism may 
represent a common framework at the basis of the selective vulnerability of neural 
progenitors. 
Milestone events in cortical development. 
In vertebrates, the earliest stages of brain development require the segmentation of neural 
tube along a head-to-tail (anteroposterior) and back-to-front (dorsoventral) axes [5]. The 
first population of neural progenitors consists of neuroepithelial cells (NECs), which 
expand their pool by undergoing a series of symmetric proliferative divisions [6]. Then, 
NECs become more fate-restricted radial glial cells (RGCs). RGCs are bipolar cells that 
retain an apical-basal orientation and express astroglial markers [7] [8]. RGCs contact the 
pial surface and the ventricular surface trough their basal and apical process, respectively. 
The onset of neurogenesis is determined by asymmetric division of RGCs cells, i.e. 
divisions that generate two different daughter cells. RGC asymmetric divisions can be 
directly neurogenic, when they produce an RGC and a neuron, or may generate an RGC 
and a more fate-restricted, Basal Progenitor (BP). BPs undergo one or few rounds of 
symmetric divisions before giving rise to post-mitotic neuroblasts and are one of the major 
sources of cortical neurons [9]. RGCs may also divide symmetrically to generate two BPs 
or two neurons [10]. Different daughter cells are spatially segregated: RGCs cell bodies 
are restricted to the more apical part of the cortical wall, corresponding to the ventricular 
zone (VZ); BPs bodies form a more basal layer known as the subventricular zone (SVZ). 
Importantly, additional progenitor populations have been described, such as the basal RG-
like cells [11], which are located abventricularly and are found abundantly in brains of 
gyrencephalic species, such as human, monkey and ferret. Newborn cortical neurons 
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migrate along the intermediate zone (IZ) to reach the cortical plate (CP), where they 
accumulate below the basal lamina. Later-born neurons arriving in the CP migrate past 
earlier born neurons in an inside-out fashion, thus generating multi-layered neocortex. 
General impact of genomic stability on brain development and function 
Genomic instability (GIN) is defined by an increased mutation rate, due to inactivation of 
DNA repair pathways or to increase of genotoxic stress from cellular processes that 
overcome high-fidelity DNA repair. Chromosomal instability (CIN) is a subset of GIN, 
characterized by altered stability of chromosomes, leading to amplification, deletion or 
rearrangement of long chromosomal fragments [12] [13]. GIN may result from 
abnormalities in different steps of cell cycle, including DNA replication [14], abnormal 
chromosome segregation [15] or abortive cytokinesis [16]. CIN and GIN are especially 
harmful to cells that continue to proliferate, as they are able to deregulate cell division and 
prompt senescence, cell death, or uncontrolled proliferation. However, CIN and GIN can 
also be detrimental in long-lived post-mitotic cells, since they may alter gene expression 
programs and lead to the production of abnormal proteins [17]. On this basis, it is not 
surprising that genetic and non-genetic alterations leading to CIN and GIN have profound 
consequences on CNS development, which is characterized by explosive waves of cell 
proliferation and generates cells with the longest lifespan in the body. Indeed, CNS is 
consistently affected in most conditions resulting in CIN and GIN. Interestingly, although 
these conditions should generically affect all proliferating cells in the body, in many cases 
the severity of CNS alterations is disproportionate if compared to other tissues, indicating 
that CNS development and function have specific vulnerability factors. In particular, neural 
progenitors show strong sensitivity to DNA damage [18], which may change at different 
developmental stage [19]. 
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One of the most dramatic evidences of this sensitivity has been provided by follow-up 
studies of atomic bomb survivors in Hiroshima and Nagasaki, showing that the frequency 
of microcephaly in new-borns exposed to radiations in utero increased ten times more than 
the incidence of radiation-induced tumors [20]. In addition, a huge array of human 
syndromes characterized by neurodevelopmental defects, neurodegeneration or brain 
tumors display defects in DNA damage signalling [21]. 
This peculiar sensitivity has been correlated with the relatively low capability of different 
neural progenitors to cope with DNA damage. It has been shown that neuronal progenitors 
process IR induced DNA damage more slowly than neurons and, as a consequence, are 
also more susceptible to IR induced apoptosis [22] [23]. A second factor that may justify 
the specific susceptibility of different neural progenitors to genotoxic insults is the different 
duration of their cell cycle phases. G1 phase lengthening is associated with differentiating 
progenitors [24]: neural progenitors undergoing rapid expansion have longer S phase, 
compared with progenitors committed to the neurogenic lineage [25]. Longer replicative 
phase during early progenitor expansion may facilitate accurate DNA repair through 
homologous recombination (HRR), which requires more time to be completed than non-
homologous end joining (NHEJ) [26], thus avoiding transmission of genetic errors to a 
large population of brain cells. On the other hand, differentiating progenitors rely more on 
NHEJ to repair DSBs [27], which can be more effective for coping with the high replicative 
stress associated with rapid proliferation of late neural progenitors [28] [29] [30].  
Many knock out mouse models of DNA repair genes, such as Polb mutants [31],  show 
lethal phenotypes due to neuronal defects. 
Differential usage of DNA repair pathways at different developmental stages, associated 
with a different apoptotic threshold, may justify most of the specific effects of GIN. For 
instance, mice defective for NHEJ because of DNA ligase IV (Lig4) inactivation show DNA 
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damage-induced apoptosis in postmitotic differentiating immature neurons, while HRR-
deficient Xrcc2 knockout mice show apoptosis only in neural precursors cells, thus 
suggesting that during early development DSB are repaired mainly using HRR [27]. 
Another example of differential requirement of DNA damage response (DDR) factors 
during development is the conditional ablation of Topbp1, which is an activator of ATR 
during DDR and an important factor to maintain DNA integrity during replication. Deletion 
of Topbp1 in early cortical progenitors, by using an Emx1-Cre driver, leads to 
microcephaly and strong apoptosis during development. In contrast, deletion at later 
stages using Nes-Cre results in similar levels of DNA damage but attenuated apoptosis. In 
addition to the temporally-restricted dependence on different DNA repair pathways, these 
data suggest that neural progenitors have different threshold for apoptosis at different 
developmental stages and support the idea that apoptosis in early progenitors might be a 
crucial mechanism to ensure genome integrity in CNS [32] [29] [28].  
Neurons display high sensitivity to GIN even after the end of development. The high levels 
of oxidative metabolism that characterize brain produces a high burden of reactive oxygen 
species, which are the main cause of SSB. Transcription associated breaks [33] and 
neurotransmission-associated stress are additional SSB sources [34]. Accordingly, most 
patients bearing mutations in gene responsible to sense or repair SSB display neurological 
syndromes [32]. 
DNA damage sensing pathways and cortical development.  
In all tissues, DNA damage is sensed by genome surveillance pathways that may prevent 
cell cycle progression, or initiate apoptosis, thus allowing DNA repair or preventing the 
potential danger posed by damaged cells [35]. Genome surveillance is ensured by three 
PI3K-like protein kinases: ATM (ataxia-telangiectasia, mutated), ATR (ATM and Rad3-
related) and PRKDC (the catalytic subunit of the DNA-dependent protein kinase) [23]. The 
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relative importance of individual kinases in CNS development is dependent on the type of 
DNA lesion and cells [36]. ATR exerts a prominent role in protecting cells from DNA 
damage arising during S-phase in consequence of DNA stressors like ultraviolet radiation, 
DNA polymerase inhibitors, nucleotide depletion or DNA crosslinkers, leading to DNA 
polymerase slowing or stalling [23]. These agents converge on formation of single 
stranded DNA (ssDNA) stretches at the replication fork, which may produce replication 
intermediates leading to high risks of mutation and/or genomic rearrangements. Canonical 
ATR pathway activation is triggered when the replication protein A complex (RPA) binds to 
ssDNA, generating a recruitment platform for different proteins, including ATR-interacting 
protein (ATRIP), which in turn recruits ATR. In addition to ATR-ATRIP complex formation, 
full ATR activation requires the simultaneous presence on ssDNA of the heterotrimeric 
ring-shaped complex RAD9–RAD1–HUS1 [37]. This complex locally recruits TOPBP1 
that binds to and activates ATR, leading to phosphorylation of checkpoint kinase-1 
(CHK1) and other downstream ATR effectors, which slow origin firing, arrest cell-cycle, 
stabilize and restart stalled replication forks [38]. In contrast, ATM and PRKDC are 
activated by DNA double strand breaks (DSBs) and exert a pivotal function in DSB 
recognition [23]. When DSB are recognized by the MRN complex (MRE11-RAD50-NBS1), 
ATM is recruited at DNA damage sites, leading to phosphorylation of H2AX histone variant 
at S139 (γH2Ax) in proximity of the break. γH2Ax binds to MDC1, which further amplifies 
the signal by recruiting more MRN molecules and TP53BP1 [39]. ATM activation is crucial 
in preventing DNA-damaged cells from entering S-phase. ATM also activates TP53, which 
in turn induces cell cycle blocker CDKN1A (p21CIP1) as well as apoptosis-initiating genes. 
Most DSB occurring outside S phase are repaired by NHEJ independently of ATM, but a 
minority of DSBs located in heterochromatic regions or with blocked ends, require 
processing in a ATM dependent fashion. PRKDC is engaged to DSBs by the heterodimer 
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complex KU70/80 to form the DNA-PK holoenzyme and facilitate DNA repair via NHEJ 
[40]. However, NHEJ core components inactivation leads to extensive neural apoptosis 
and embryonic lethality, while mice lacking PRKDC are viable [41] [42]. How these three 
kinases collectively organise the responses to DNA damage has been elegantly 
demonstrated by Enriquez-Rios and colleagues: mice bearing single or combined 
mutations of Atm, Atr or Prkdc showed  differential cellular sensitivity in response to IR 
[36]. Authors confirmed that ATM transduces pro-apoptotic signals in non-cycling cells, 
while it turned out to be less important in replicating progenitors in VZ. In contrast, ATR 
deletion did not affect the increased apoptosis induced by IR in presence of PRKDC loss. 
Interestingly, apoptosis levels were increased by PRKDC loss even when both ATM and 
ATR were deleted (triple knockout mice), implying the existence of an additional, non-
defined pathway converging on TP53 activation. In humans, PRKDC mutations have been 
associated to a rare syndrome characterized by immune-deficiency and microcephaly [43] 
[44]. ATM loss is responsible for the neurodegenerative syndrome ataxia telangiectasia, 
while hypomorphic ATR mutations are associated with one of the complementation groups 
of Seckel syndrome (SCKS) [45] [29] (see below).  
In summary, the DNA-damage sensors ATR and PRKDC appear to be crucial for coping 
with endogenous and exogenous replication-related stress arising during embryonic 
development. Neural tissue could be affected more than other districts because of the 
stress imposed by the explosive proliferation of neural progenitors, that especially 
characterize late-born neurons [46]. On the other hand, ATM is much more important for 
post-mitotic neurons, but in this case the reasons for specificity remain undefined. 
 
DNA repair pathways in cortical development. 
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In human gestation, cortical neurogenesis lasts for a long period, spanning from  7th till 
28th week [47]. Neural progenitors, committed progenitors and differentiated cells are 
continually under threat by lesions from endogenous or exogenous sources. Base 
modifications, similar to those induced by ultraviolet radiation, may distort the helical 
structure of the DNA and are repaired by the nucleotide excision repair pathway (NER), 
while DNA base modifications caused by alkylation, deamination or oxidation, such as 
those induced by reactive oxygen species (ROS), are mainly repaired by the base excision 
repair pathway (BER). DNA double-strand breaks (DSB) are the most harmful type of DNA 
lesion,  which if left unrepaired or not correctly repaired may lead to apoptosis or 
mutagenic rearrangements, such as translocations [35]. DSBs may be generated 
exogenously, by Ionizing Radiations (IR) or different chemical agents (such as 
chemotherapeutic drugs), or endogenously, by prolonged replication fork stalling or ROS 
[48]. DSBs can be managed by cells through two different core pathways: HRR and NHEJ 
[49].  
Base Excision Repair 
The most common DNA lesion, DNA single strand break (SSB), may be produced by ROS 
reaction with the deoxyribose sugar of DNA, as normal enzymatic intermediate of Base 
Excision Repair (BER) pathway, from catalytic intermediates generated by topoisomerase 
1 (TOP1) to resolve supercoiled structures during replication, transcription or other events. 
Given the different sources of SSBs, chemical composition of SSB ends can be highly 
heterogeneous and a wide variety of sub-pathways of SSB repair have evolved. Persistent 
SSBs may lead to replication fork collapse during chromosome duplication with 
consequent formation of DSBs, as well as transcription block in non-proliferating cells [32]. 
To deal with oxidation, deamination and spontaneous hydrolysis of bases, specific 
subtypes of BER operate during all stages of the cell cycle and exert a key function in both 
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dividing and non-dividing cells. The sequence of BER is started by a lesion-specific DNA 
glycosylase, which recognizes and hydrolyzes the N-glycosidic bond of a substrate base, 
generating an apurinic/apyrimidinic site intermediate. Apurininc sites, which can be formed 
frequently by spontaneous or damage-induced hydrolysis of the N-glycosidic bond, are cut 
by an endonuclease, APEX1. This protein works in coordination with PNKP to generate 5’-
P and 3’-OH priming group, for repair synthesis and ligation. BER then engages Pol β, to 
replace the missing nucleotide (shortpatch repair) or Pol δ/ε in collaboration with PCNA, to 
perform displacing synthesis during S phase or when ATP concentrations are low 
(longpatch repair). Finally, the repair factor complex XRCC1 and XRCC1 and DNA ligases 
LIG1 or LIG3 seal the remaining nick [50]. Mutations in genes encoding for BER 
components such as APTX, TDP1 or PNKP may produce different CNS phenotypes. 
TDP1 mutations cause a neurodegenerative disorder, Spinocerebellar ataxia with axonal 
neuropathy (SCAN1) [51], while mutations in APTX are responsible for Ataxia-ocular motor 
apraxia 1 (AOA1) [52]. PNKP mutations may result in neurodegeneration (AOA4) [53], but 
may also cause a neurodevelopmental disorder, Microcephaly with Seizures (MCSZ) [54]. 
This heterogeneity could be explained by the dual role played by PNKP, which is a key 
factor in BER, but is also involved in NHEJ through its interaction with XRCC4. PNKP is 
thus involved in repair of both SSBR and DSBR [55] [32], but it is likely to play a role only 
in a fraction of breaks repaired by NHEJ after IR damage [56]. 
Nucleotide Excision Repair 
Nucleotide excision repair (NER) is a repair system capable of removing a wide variety 
of DNA helix-distorting lesions, such as base modifications or UV-induced photolesions 
and DNA adducts induced by chemicals like N-acetoxy-2-acetylaminofluorene or 
aflatoxinB1. Patients bearing congenital defects in NER components are peculiarly 
sensitive to sunlight, and suffer for cancer predisposition and/or premature aging [57].  
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NER pathway is very important during neural progenitor proliferation, as NER can cope 
with stalled RNA polymerase or abortive transcripts, monitor DNA integrity and activate 
DNA damage signaling. In this repair system, a central role is exerted by components of 
the basal TFIIH transcription and repair complex, required for RNA pol II function. This 
system is responsible for transcription coupled repair (TCR), as well as for transcription-
independent global genomic repair (GGR). It is worth noticing that mutations involving 
TCR lead to neuropathology, while those affecting GGR have much milder neurological 
implications. The two pathways share a high number of repair factors but differ during 
the DNA damage recognition phase [48]. In TCR, DNA lesions affect a transcribed gene 
and are sensed in consequence of RNA Pol II stalling. In this case, the repair process is 
initiated by ERCC6 that, in turn, recruits ERCC8. Instead, the proteins required to 
recognize DNA damage in GGR are XPC and XPE. For both pathways DNA damage 
verification and unwinding is carried out by TFIIH, a DNA-dependent ATPase and 
helicase activity that, in complex with ERCC3 or ERCC2, opens up the DNA helix 
around the lesion. Finally, the DNA strand that contain the lesion is cut at the single- to 
double-strand DNA transitions by the structure-specific endonucleases ERCC5 and 
ERCC1, gap filling is carried out by DNA Pol δ/ε using undamaged strand as a template 
and the nick is sealed by DNA ligase I or III [58]. Mutations in several components of the 
NER pathway can lead to the human syndromes Xeroderma Pigmentosum (XP), 
Cockayne Syndrome (CS), and Trichothiodystrophy (TTD). Defects in NER components 
may lead to a complex relationship between genetic alterations and clinical phenotype 
[59]. While mutations in different genes, grouped in eight XP complementation groups, 
lead to very similar phenotypes, different mutations in just one gene (ERCC2) may lead to 
6 different clinical disorders: XP, XP with neurological disease, TTD, XP/CS complex, 
XP/TTD complex or  
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Cerebro-oculo-facio-skeletal syndrome. XP is rare disease affecting the skin and leading 
to neurodegeneration (that results in brain atrophy). Exposure of these patients to 
sunlight results in a high incidence of skin and mucous membrane cancer, squamous 
and basal cell carcinomas and melanomas [60]. However, mutations in ERCC8 or 
ERCC6, lead to CS. CS is a developmental and neurological disorder, associated with 
reduced lifespan without an increased incidence of cancer. In this case, neuropathology 
is profoundly different from that associated with XP, as CS is characterized by 
microcephaly with intellectual disability. Microcephaly in CS is likely due to combination of 
defective cortical development and progressive brain atrophy. In addition, vasculopathy 
and calcification of the basal ganglia may also be observed. To complicate even further 
the situation, CS may be caused by mutations in ERCC2, ERCC3 or ERCC5 [61]. TTD is 
a rare autosomal recessive disorder characterized by sulphur deficient brittle hair, 
sometimes accompanied by facial dysmorphism and intellectual disability. TTD arises 
from mutations in the gene encoding ERCC2 helicase or, less frequently, ERCC3 or 
GTF2H5 proteins. The neurological abnormalities observed in TTD include developmental 
microcephaly associated with intellectual disability, deafness and ataxia [62]. 
Similar to CS, TTD may further affect cortical development by altering myelin formation. 
Moreover, neurological defects observed in TTD patients may be due to the deregulation 
of thyroid hormone target genes in the brain [63]. 
Homologous Recombination Repair and Fanconi Anemia pathways.  
In cycling neural progenitors, genomic fidelity during replication is ensured by HRR. HRR 
is considered an error free mechanism, occurring during S or G2 phase of the cell cycle. 
During the initial stages of HRR, ATM and ATR kinases recognizes double-strand DNA 
break and phosphorylate downstream targets such as H2AX, BRCA1, CHEK2 and TP53. 
BRCA1, along with BARD1 and BRIP1, acts as a scaffold that coordinates proteins at the 
14 
 
damage site [64]. HRR requires a sister chromatid as a template to repair DNA and is 
initiated by the MRE11-RAD50-NBS1 complex, in collaboration with RBBP8, which 
generates 3' ssDNA overhang for strand exchange [65]. MRN complex participates in both 
HR and NHEJ (see below); in contrast RBBP facilitates HR, while suppressing NHEJ [66] 
[67]. RAD51 is recruited to 3' ssDNA overhangs through a complex mechanism involving 
the RPA, BRCA2, BRCA1 and XRCC2 proteins, to form RAD51 nucleoprotein filaments, 
which are essential for strand invasion of the intact homologous DNA region used as a 
template for repair. Studies in knockout mouse models have shown that HRR genes are 
fundamental for brain development [68–70]. In humans, mutations in these genes have 
been associated with heterogeneous clinical manifestations, which may (BRCA1) [71] [72] 
or may not (BRCA2) include microcephaly [73] [74]. One of the peculiar phenotypes that 
may derive from HRR pathway mutations is Fanconi Anemia (FA), a clinically and 
genetically heterogeneous disorder mainly characterized by bone marrow failure and 
cancer predisposition. However, some patients also display microcephaly and dwarfism 
features, reminiscent of Seckel syndrome [75]. To date, at least eighteen FANC genes are 
associated with patient mutations. The FA nuclear complex, composed of FANCA, 
FANCC, FANCG and FANCF proteins, is essential for protection against chromosome 
breakage. The core complex of the FA pathway is necessary to monoubiquitylate a 
specific site in each protein of the FANCI/FANCD2 (ID2) heterodimer. Monoubiquitination 
of ID2 triggers nucleases SLX4 and ERCC4, as well as downstream repair factors that 
include BRIP, BRCA2, PALB2, and RAD51C [76]. The latter two genes are in common 
with the HRR pathway. FA proteins have a prominent role in promoting the repair of DNA 
interstrand crosslinks (ICLs) [77]. Unrepaired ICLs are very harmful, especially in dividing 
cells, as they prevent strand separation, thereby stalling DNA replication and leading to 
chromosomal instability [78]. FA pathway is closely dependent on ATR and CHEK1 
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function. Indeed, ATR deficient cells are hypersensitive to ICLs, and many FA proteins , 
such as FANCD2, FANCA, FANCI and FANCE, are direct substrates of ATR or CHEK1 
[79]. 
Non-Homologous End Joining  
NHEJ, which works in both non-replicating and replicating cells, is the predominant DSB 
repair system in higher eukaryotes. NHEJ involves ligation of two broken DNA ends 
without needing a repair template. NHEJ core factors, including XRCC4, LIG4 and NHEJ1, 
associate with DSB after PRKDC recruits Ku proteins to the broken ends, which are 
subsequently closely aligned and ligated. The repair of some DSBs by NHEJ may require 
additional accessory proteins, such as DNA polymerases and nucleases. One of such 
factors is DCLRE1C, an endonuclease interacting with PRKDC to promote repair of a 
subset of DSBs [80] [81] [82]. Indeed, PRKDC recruits DCLRE1C to promote DNA-end 
processing [83] [84].  
Although NHEJ is often described as an error prone and mutagenic process, it is more 
efficient and accurate than previously thought [85]. Only when classical NHEJ (cNHEJ) 
fails, cells use an alternative end-joining pathway mediated by DNA polymerase theta, 
the so called theta‐mediated end‐joining (TMEJ), which can easily introduce mutations 
([86], [87]. The study of mice mutated for genes important in NHEJ [88] showed elevated 
apoptosis and enhanced IR sensitivity in cortical progenitors. NHEJ is the main repair 
pathway in differentiating and post-mitotic neurons [89]. NHEJ is also required during 
immune system development for V(D)J and Class Switch Recombination mechanisms 
[90]. For these reasons, congenital defects in NHEJ pathway components such PRKDC 
[44], LIG4 [91] and genes encoding XRCC4 and NHEJ1 [92] [74] are associated with 
developmental delay, malignancy, variable degree of immunodeficiency and microcephaly. 
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The  MCPH-SCKS spectrum: many roads leading from genomic instability to 
primary microcephaly.  
Severe congenital microcephalies are characterized by reduced head circumference at 
birth, to at least 3 standard deviations below the mean [1] [93]. The two main clinical 
phenotypes are referred to as primary hereditary microcephaly (MCPH) and Seckel 
syndrome (SCKS) [1] [93]. In MCPH, brain size reduction is the main clinical feature, 
associated with conserved brain architecture and mild to moderate intellectual disability. 
MCPH is a genetically heterogeneous condition, with at least 18 complementation groups. 
Most of the genetic defects identified in MCPH involve genes that play fundamental roles 
in various processes that collectively enable cells to faithfully segregate chromosomes and 
allow correct progression of mitotic division [94]. These defects may range from abnormal 
microtubule formation, stabilization and polymerization, to alteration of spindle structure, 
defective centrosome function, along with impaired cell cycle checkpoint function. Although 
these disfunctions may all indirectly lead to CIN and GIN (see below), some of MCPH 
genes have a more direct involvement in DNA repair and chromosome stability. Under this 
point of view, the case of MCPH1 is particularly striking, because this multifunctional gene 
may affect diverse aspects of cell cycle regulation and integrity. MCPH1 [95] [96] encodes 
for a centrosomal protein containing three BRCT (BRCA1 C-terminal) domains. Various 
studies demonstrated that MCPH1 plays an important role in G1/S and G2/M checkpoint 
regulation and in maintaining telomere integrity [97]. MCPH1-deficient cells exhibit mitotic 
defects, such as a prophase-like state and premature chromosome condensation [98] [99]. 
MCPH1 plays a crucial role in different aspects of DNA damage response downstream of 
both ATM and ATR pathways. Indeed, MCPH1 is concentrated at DNA damage foci in 
response to UV or IR treatment, colocalizing with γH2AX, TP53BP1, pATM, ATR and RPA. 
In MCPH1-deficient cells, the IR-induced formation of TP53BP1 and pATM foci or RPA 
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recruitment to ssDNA are impaired. ATR signaling amplification under replication stress 
requires MCPH1 to recruit TOPBP1 [100]. Moreover, during HRR, MCPH1 binds to 
BRCA2 and regulates the localization of BRCA2 and RAD51 at DNA damage sites [101]. 
In addition, MCPH1 transcriptionally regulates CHK1 and BRCA1 expression, by 
interacting with E2F1 on their promoters [102]. Finally, MCPH1 directly acts on chromatin 
structure, facilitating the access of repair proteins to DNA damage sites, by interacting with 
the chromatin remodeling complex SWI/SNF in an ATR-dependent manner [103]. 
Chromatin remodeling is also regulated by PHC1, a human homologue of the Drosophila 
Polyhomeotic gene, which takes part to the Polycomb Repressive Complex 1 and is 
mutated in MCPH11. Cells defective for PHC1 show enhanced levels of the DNA 
replication inhibitor GMNN, accumulate DNA damage and are defective in DNA repair and 
proliferation after IR treatment [104]. A direct involvement in GIN has recently been 
proposed for ASPM, the most frequently mutated MCPH gene [105]. ASPM-dependent 
microcephaly (MCPH5) is commonly believed to result from abnormal spindle function and 
positioning, leading to the alteration of symmetric to asymmetric cell division [106]. 
However, ASPM levels are influenced by IR and ASPM affects efficient DSB repair and 
reduces DNA damage during cerebellar granule neuron progenitors cell proliferation [107] 
[108]. Another multifunctional gene causing MCPH is Citron Rho-Interacting Kinase (CIT), 
encoding Citron kinase protein (CITK). CITK localizes at the centrosomes and midbody, 
where it plays a major role in regulating the stability of the microtubule cytoskeleton. 
Mutation of CIT lead to apoptosis in neural progenitors, newborn neurons and in male 
germ cells [109] [110] [111], which was initially proposed to result from cytokinesis failure 
[112]. In addition, mouse Cit-mutant neural progenitors show aberrant cleavage plane 
orientation [113] and accumulate DNA double strand beaks [114]. The latter phenotype 
correlates with defective RAD51 localization to DNA damage foci and is probably 
18 
 
responsible of the apoptotic phenotype through TP53 activation [114]. Altogether, these 
studies underscore that maintenance of genome stability is a critical functional aspect 
common to many of MCPH genes.  
On the other hand, SCKS is characterized by intrauterine growth retardation, severe 
proportionate short stature, profound microcephaly with intellectual disability and 
characteristic craniofacial features, in the absence of visceral malformations.  
In addition to ATR mutation, SCKS can be caused by mutation of RBBP8, CENPJ, 
CEP152, CEP63, NIN, DNA2, TRAIP  and NSMCE2. However, patients carrying mutations 
in some of these genes may show phenotypes intermediate between SCKS and MCPH, or 
even pure MCPH. These genes include RBBP8, CEP152 (involved in 
MCPH9), CENPJ (involved in MCPH6), CEP63, and PHC1 (involved in MCPH11). 
Therefore, while in the past SCKS and MCPH were discriminated by height, the most 
recent view is that the two phenotypes define the extremes of a spectrum of phenotypes in 
which genomic stability of neural progenitors is mostly compromised.   
Centrosomes and chromosome segregation at the core of genome stability and 
neurologic disease 
Centrosome is the main microtubule-organizing center (MTOC), essential for coordinating 
cell cycle progression, mitotic cell division, cilia formation and DNA damage response 
[115]. Moreover, in cortical neural progenitors, centrosome plays a pivotal role in 
regulating cleavage plane orientation [116], cell fate decision and neuronal migration [117]. 
During mitosis, an intact centrosome number is pivotal for correct chromosome 
segregation and to maintain genomic integrity. Alteration of centrosomes’ number and 
function can impact on genome stability in different ways. Increased centrosome number 
may lead to multipolar mitoses, which may result in mitotic catastrophe or undergo bipolar 
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resolution [118]. Even in this case, there is a high frequency of abnormal microtubule to 
kinetochore attachments, resulting in chromosome missegregation [118]. The latter event 
may lead to aneuploidy, DNA damage through micronuclei formation, or even cytokinesis 
failure ending up with polyploidy [119]. These defects can result from either complete loss 
of centrosomes, disruption of normal centrosome activity, or from defects in centrosome 
separation [120]. All these events may have a profound importance on cortical 
development [121–123]. 
Therefore, it is not surprising that mutations in genes encoding structural centrosome 
components or centrosome-associated proteins are the most frequent cause of MCPH 
(CEP152, CEP63, SASS6, STIL, CENPJ, CEP135, CDK5RAP2, CDK6, ASPM and 
WDR62), and Microcephalic primordial dwarfism (MPD) [124] [1] [125]. The importance of 
correct chromosome segregation is further suggested by the occurrence of microcephaly 
in the so called "condensinopathies", i.e. genetic syndromes deriving from mutations in 
components of condensin complexes (NCAPD2, NCAPH or NCAPD3) [126]. 
Condensinopathies are characterized by inappropriate chromosome compaction and 
decatenation, chromosome segregation errors and micronucleus formation, with 
consequent increased frequency of aneuploidy [126]. Of note, the function of Condensin II 
complex is regulated by MCPH1, explaining the premature chromosome condensation 
(PCC) defect observed in cells derived from MCPH1 patients [127]. It is also emerging that 
centrosomes could be important integration points for DNA repair pathways and control 
cell cycle progression after DNA damage. Indeed, some DDR players such as ATM, ATR, 
CHEK2, CHEK1, BRCA1, BRCA2 and PARPs may localize to the centrosome. 
Centrosomal localization of CHEK1 is important to inactivate the phosphatase CDC25, 
which is an activator of CDK1-cyclinB, the M phase promoting factor [128]. MCPH1 
controls the localization of CHEK1 to centrosomes and its loss causes premature CHEK1 
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activation and early mitotic entry, thus uncoupling mitosis and the centrosome cycle [129]. 
Moreover TP53, a common effector of the DNA damage response implicated in cell cycle 
progression, DNA repair and apoptosis, can localize to centrosome after DNA damage, in 
an ATM dependent manner [130]. Another important link between DDR and centrosome is 
the observation that nuclear-cytoplasmic trafficking of DDR proteins occurs on 
microtubules and is dependent on dynein. Interestingly, microtubule-targeting agents (e.g. 
taxanes), can alter the intracellular distribution of several DDR proteins (ATM, ATR, 
PRKDC, MRE11, RAD50, TP53, NBS1, TP53BP1, and TP63) [131]. Finally, microtubules 
are required to control chromatin mobility, in particular in case of DNA break, where an 
enhanced chromatin moving seems to be important to "expose" the damage and allow 
DDR factors to reach and repair the lesion [132]. An additional link between centrosome 
and DNA damage response is represented by SCKS and FA, which display centrosomal 
disfunction and DDR impairment. SCKS may arise from mutations in centrosomal proteins 
CEP152 or PLK4  [133] [134] [135], leading to impaired centrosome biogenesis, 
supernumerary centrosomes and impaired cell cycle progression, together with genomic 
instability and defective DDR. Loss of FA signaling can weaken the spindle assembly 
checkpoint (SAC), which in normal conditions prevents separation of the 
duplicated chromosomes until each chromosome is properly attached to the spindle 
apparatus. FA deficient cells display chromosome instability caused by abnormal cell cycle 
progression, cytokinesis failure and accumulation of ultrafine bridges. Moreover FA 
deficient cells accumulate DNA damage since they are hypersensitive to some metabolic 
by-products such as aldehydes [75].  
Perspectives and conclusions 
Knowledge of the fundamental processes underlying brain cortex development has grown 
exponentially during the last few years. These studies have underscored the crucial 
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relevance for brain development and physiology of the different pathways that have 
evolved to ensure faithful duplication, transmission and maintenance of the genomic 
information. At the same time, these studies have started to unravel the complex 
interrelation between the molecular details of these pathways and the phenotypic 
spectrum of CNS abnormalities produced by their alterations. Of particular relevance, the 
centrosome is progressively emerging as a possible integration hub for molecular events 
specifically important for neurogenesis. It is therefore easy to foresee that the study of 
genome stability maintenance in CNS will be a very interesting topic for future studies. 
Among the most interesting challenges, it will be important to determine how centrosome 
functions and DDR are finely orchestrated and why neurogenesis is so sensitive to their 
alterations. Moreover, it appears very important to better define the role of microtubules in 
this context. A deeper knowledge of these phenomena could be critical to better 
understand why alterations of apparently different pathways produce similar phenotypes, 
as well as how different mutations of the same gene may result in completely different 
pathologies. 
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Figure legends 
 Figure 1 
Multiple kind of genome lesions can impact the nervous system at all stages of 
development and maturity. Replication stress primarily affects proliferating neural 
progenitors that may require DNA DSB repair, which involves either HR or NHEJ. HR is 
dependent on using replicated sister chromatids as an error-free repair templates and is 
not active in non-replicating or differentiated cells. In this phase, ATR exerts a prominent 
role in protecting cells from DNA damage arising during S-phase in consequence of DNA 
stressors.  Replicating cells may also experience other types of damage, including inter-
strand crosslinks or strand breaks from other sources, including oxidative lesions and 
transcription-associated damage. ATM and DNA-PK are activated by DNA DSBs and exert 
a pivotal function in DSB recognition. In non-cycling cells, NHEJ repairs DNA DSBs, 
whereas other types of DNA damage require the BER/ single-stranded break repair 
(SSBR) pathway or NER. Oxidative damage can also impact immature cells but will be an 




Cellular defects that impair the fidelity of mitosis promote chromosome mis-segregation 
(Chromosome Instability CIN) and aneuploidy. Increasing evidence reveals that errors in 
mitosis can also promote the direct and/or indirect acquisition of DNA damage and 
chromosome breaks. Unrepaired DNA damage is also deemed a contributor to 
aneuploidy, which might be especially relevant in the central nervous system (CNS) due to 
evidence for a low repair capacity of neuronal precursors and differentiated neurons. The 
induction of DNA damage may lead to apoptosis, which occurs in the majority of conditions 
described in this review. In contrast, some MCPH, Seckel syndrome and FA are 
characterized by cell cycle arrest due to mitotic alterations. Color-coded bars indicate the 
relative contribution to the cortical phenotype from cell cycle arrest (green) and apoptosis 
(blue). MCPH1: all the genes mutated in MCPH that show mitotic alterations. MCPH2: 
MCPH1, ASPM, CITK 
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